Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

Z. Chen, W. Wang, J. E. Cortes, E. Liu, R. N. Miranda, C. Zhao, J. Yuan, X. Lu, W. Yang, M. D. Ameri, H. M. Kantarjian, L. J. Medeiros, S. Hu

Research output: Contribution to journalLetter

Original languageEnglish (US)
Article numbere418
JournalBlood Cancer Journal
Volume6
DOIs
StatePublished - May 6 2016
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. / Chen, Z.; Wang, W.; Cortes, J. E.; Liu, E.; Miranda, R. N.; Zhao, C.; Yuan, J.; Lu, X.; Yang, W.; Ameri, M. D.; Kantarjian, H. M.; Medeiros, L. J.; Hu, S.

In: Blood Cancer Journal, Vol. 6, e418, 06.05.2016.

Research output: Contribution to journalLetter

Chen, Z. ; Wang, W. ; Cortes, J. E. ; Liu, E. ; Miranda, R. N. ; Zhao, C. ; Yuan, J. ; Lu, X. ; Yang, W. ; Ameri, M. D. ; Kantarjian, H. M. ; Medeiros, L. J. ; Hu, S. / Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. In: Blood Cancer Journal. 2016 ; Vol. 6.
@article{b89e79cbb7974acaa1bef55269115c57,
title = "Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy",
author = "Z. Chen and W. Wang and Cortes, {J. E.} and E. Liu and Miranda, {R. N.} and C. Zhao and J. Yuan and X. Lu and W. Yang and Ameri, {M. D.} and Kantarjian, {H. M.} and Medeiros, {L. J.} and S. Hu",
year = "2016",
month = "5",
day = "6",
doi = "10.1038/bcj.2016.27",
language = "English (US)",
volume = "6",
journal = "Blood Cancer Journal",
issn = "2044-5385",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy

AU - Chen, Z.

AU - Wang, W.

AU - Cortes, J. E.

AU - Liu, E.

AU - Miranda, R. N.

AU - Zhao, C.

AU - Yuan, J.

AU - Lu, X.

AU - Yang, W.

AU - Ameri, M. D.

AU - Kantarjian, H. M.

AU - Medeiros, L. J.

AU - Hu, S.

PY - 2016/5/6

Y1 - 2016/5/6

UR - http://www.scopus.com/inward/record.url?scp=84967110038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84967110038&partnerID=8YFLogxK

U2 - 10.1038/bcj.2016.27

DO - 10.1038/bcj.2016.27

M3 - Letter

C2 - 27152845

AN - SCOPUS:84967110038

VL - 6

JO - Blood Cancer Journal

JF - Blood Cancer Journal

SN - 2044-5385

M1 - e418

ER -